1. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease 
Shailja C. Shah, Joren R. ten Hove, Daniel Castaneda, Carolina Palmela, Erik Mooiweer, Jean-Frédéric Colombel, Noam Harpaz, Thomas A. Ullman, Ad A. van Bodegraven, Jeroen M. Jansen, Nofel Mahmmod, Andrea E. van der Meulen-de Jong, Cyriel Y. Ponsioen, Christine J. van der Woude, Bas Oldenburg, Steven H. Itzkowitz, Joana Torres 
Clinical Gastroenterology and Hepatology 
Volume 16, Issue 7, Pages e3 (July 2018)
DOI: /j.cgh
Copyright © 2018 AGA Institute Terms and Conditions

2. Figure 1
Description of patient selection and main outcomes in each database. NL, The Netherlands.
Clinical Gastroenterology and Hepatology  , e3DOI: ( /j.cgh )
Copyright © 2018 AGA Institute Terms and Conditions

3. Figure 2
Kaplan–Meier time-to-event (aCRN) analysis, all patients since study entry.
Clinical Gastroenterology and Hepatology  , e3DOI: ( /j.cgh )
Copyright © 2018 AGA Institute Terms and Conditions

4. Figure 3
Kaplan–Meier time-to-event (aCRN) analysis, patients with LGD only.
Clinical Gastroenterology and Hepatology  , e3DOI: ( /j.cgh )
Copyright © 2018 AGA Institute Terms and Conditions

5. Supplementary Figure 1
Kaplan–Meier time-to-event (aCRN) analysis for patients with IND; time from first IND within study interval to event (P = .02, log-rank test). aCRN was defined as CRC and/or HGD.
Clinical Gastroenterology and Hepatology  , e3DOI: ( /j.cgh )
Copyright © 2018 AGA Institute Terms and Conditions